530313 logo

Kimia Biosciences Limited Stock Price

BSE:530313 Community·₹1.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

530313 Share Price Performance

₹26.78
-14.55 (-35.20%)
₹26.78
-14.55 (-35.20%)
Price ₹26.78

530313 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Fair value with mediocre balance sheet.

3 Risks
1 Reward

Kimia Biosciences Limited Key Details

₹1.3b

Revenue

₹788.7m

Cost of Revenue

₹470.6m

Gross Profit

₹380.1m

Other Expenses

₹90.5m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.91
37.37%
7.19%
311.5%
View Full Analysis

About 530313

Founded
1993
Employees
n/a
CEO
Sameer Goel
WebsiteView website
www.kimiabiosciences.com

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its products. Kimia Biosciences Limited was formerly known as Laurel Organics Ltd and changed its name to Kimia Biosciences Limited January 2019. The company was incorporated in 1993 and is based in New Delhi, India.

Recent 530313 News & Updates

Recent updates

No updates